Valbiotis SA
PAR:ALVAL

Watchlist Manager
Valbiotis SA Logo
Valbiotis SA
PAR:ALVAL
Watchlist
Price: 0.717 EUR 3.31% Market Closed
Market Cap: 17m EUR

Net Margin
Valbiotis SA

-2 363.8%
Current
-1 859%
Average
-6.6%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-2 363.8%
=
Net Income
-11.1m
/
Revenue
470k

Net Margin Across Competitors

No Stocks Found

Valbiotis SA
Glance View

Market Cap
17.2m EUR
Industry
Biotechnology

Valbiotis SA develops products and candidate drugs designed to prevent metabolic diseases. The company is headquartered in Perigny, Nouvelle-Aquitaine. The company went IPO on 2017-06-07. The firm specializes in developing nutrition solutions designed to prevent cardiometabolic diseases and provide nutritional support for patients. The company seeks to develop solutions designed to prevent type 2 diabetes, NASH, (non-alcoholic steatohepatitis) and obesity and to offer nutritional support. The firm prevents disease by developing products that reduce the risk factors of irreversible chronic diseases. The company provides patient support through new-generation medical nutrition solutions containing patented substances with clinically proven effects. Its products are plant-based and undergo strict scientific and clinical tests in collaboration with academic research centers.

ALVAL Intrinsic Value
Not Available
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-2 363.8%
=
Net Income
-11.1m
/
Revenue
470k
What is the Net Margin of Valbiotis SA?

Based on Valbiotis SA's most recent financial statements, the company has Net Margin of -2 363.8%.

Back to Top